22 employees
Isogenica operates a range of discovery platforms supported by state-of-the-art methodologies for identifying antibody and peptide ligands.
2001
$9M
from 1 investors over 1 rounds
Isogenica Limited raised $9M on November 29, 2012
Investors: Innovate UK